Arcadis: Large contract in Resilience. ASM International: Highlights from CFO roadshow. Exor: Exor buying back Exor shares. Fastned: 2H24 results, cost pressure. Flow Traders: February volumes elevated in EMEA. Montea: JV with Weerts in Belgium. Sligro: FY24 results in line, weak 1Q25 outlook. Sofina: Final NAV a tad higher. Umicore: CMD targets – no big bang
Q4 sales marginally missed our expectations, partially due to lower than expected tobacco sales. Thanks to extra efforts, underlying sales trends are improving although market condition remain subdued. Based on the Q4-24 trading update we do not expect material changes to our estimates. We maintain our Hold rating and keep our TP of EUR 14 unchanged.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.